Is pentoxifylline therapy effective for the treatment of acute rheumatic carditis? A pilot study

Journal of Paediatrics and Child Health

Volumn 39, Issue 3, 2003, Pages 214-218

  Narin, N ^a   Karakukcu, M ^a   Narin, F ^a   Akcakus, M ^a   Erez, R ^a   Halici, C ^a  

^a ERCIYES UNIVERSITY   (Turkey)

Author keywords

Acute rheumatic carditis; Interleukin 1 ; Pentoxifylline; Tumour necrosis factor

Indexed keywords

C REACTIVE PROTEIN; CYTOKINE; INTERLEUKIN 1ALPHA; PENTOXIFYLLINE; PREDNISOLONE; STEROID; TUMOR NECROSIS FACTOR ALPHA;

ADOLESCENT; ARTICLE; CARDITIS; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DRUG EFFICACY; ECHOCARDIOGRAPHY; ELECTROCARDIOGRAPHY; ERYTHROCYTE SEDIMENTATION RATE; FEMALE; HEART INDEX; HUMAN; LEUKOCYTE COUNT; MALE; PRESCHOOL CHILD; PRIORITY JOURNAL; RHEUMATIC HEART DISEASE; SCHOOL CHILD; THORAX RADIOGRAPHY; THROAT CULTURE;

EID: 0037391505     PISSN: 10344810     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1440-1754.2003.00129.x     Document Type: Article

References (16)

1. Samlaska CP, Winfield EA. Pentoxifylline. J. Am. Acad. Dennatol. 1994; 30: 603-21.
2. Ward A, Clissold SP. Pentoxifylline: a review of its pharmacodynamic and pharmacokinetic properties, and its therapeutic efficacy. Drugs 1987; 34: 50-97.
3. Elly H. Is the Pentoxifylline the drug or the decade? J. Am. Acad. Dennatol. 1994; 30: 639-42.
4. Sulliva GM, Carper HT, Novick MJ Jr, Mandell GL. Inhibition of the inflammatory action of interleukin 1 and tumor necrosis factor (alpha) on neutrophil function by pentoxifylline. Infect. Immunol. 1987; 56: 1722-9.
5. Alkharfy KM, Kellum JA, Matzke GR. Unintended immunomodulation: part II. Effects of pharmacological agents on cytokine activity. Shock 2000; 13: 346-60.
6. Karademir S, Demirçeken F, Atalay S, Demircin G, Sipahi T, Teziç T. Acute rheumatic fever in Ankara area in 1990-92 and comparison with previous study in 1980-89. Acta Pediatrica 1994; 83: 862-5.
7. Narin N, Kütükçüler N, Özyürek R, Bakiler AR, Parlar A, Arcasoy M. Lymphocyte subsets and plasma IL-1 alpha, IL-2 and TNF alpha concentrations in acute rheumatic fever and chronic rheumatic heart disease. Clin. Immunol. Immunopathol. 1995; 77: 172-6.
8. Narin N, Çiftci A, Ustünbas HB et al. High neopterin levels in acute rheumatic fever. Clin. Exp. Rheumatol. 2000; 18: 652-3.
9. Yeǧin O, Coskun M, Ertug H. Cytokines in acute rheumatic fever. Eur. J. Pediatr. 1997; 156: 25-9.
10. Dajani AS, Ayoub B, Biermann FZ et al. Guidelines for the diagnosis of rheumatic fever. Jones criteria, updated 1992. Circulation 1993; 87: 302-7.
11. Sahn DJ, DeMaria A, Kisslo J, Weyman A. Recommendations regarding quantitation in M-mode echocardiography: results of a survey of echocardiographic measurements. Circulation 1978; 58: 1072-83.
12. Strieter RM, Remick DG, Ward PA et al. Cellular and molecular regulation of tumor necrosis factor α production by Pentoxifylline. Biochem. Biophys. Res. Commun. 1988; 155: 1230-36.
13. Wakefield PE, James WD, Samlaska CP, Meltzer MS. Tumor necrosis factor. J. Am. Acad. Dermatol. 1991; 24: 675-85.
14. Diab KA, Timani MA, Bitar FF. Treatment of rheumatic carditis with intravenous gammaglobulin in acute rheumatic fever: is there a beneficial effect? Cardiol. Young 2001; 11: 565-7.
15. Dzhuzoneva BS, Nasonova VA. The results of the methazicin treatment of patient with acute rheumatic fever. Ter Arkh 1991; 63: 95-9.
16. Akcoral A, Ashn MI, Narin N. High-dose intravenous prednisolone for the treatment of children with acute rheumatic carditis. Turk. J. Med. Sci. 1992; 16: 175-82.